Background: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention initiative. Elevated opioid overdose risk following prison release means release from custody provides an ideal opportunity for THN initiatives. However, whether Australian prisoners would utilise such programmes is unknown. We examined the acceptability of THN in a cohort of male prisoners with histories of regular injecting drug use (IDU) in Victoria, Australia. Methods: The sample comprised 380 men from the Prison and Transition Health (PATH) Cohort Study; all of whom reported regular IDU in the 6 months prior to incarceration. We asked four questions regarding THN during the pre-release baseline interview, including whether participants woul...
Prisoners experience high rates of drug dependence, health problems and premature mortality. Without...
Heroin dependence is a chronic condition associated with significant health and social harms. The mo...
Background: Pre-incarceration HIV transmission behaviors and current attitudes toward opioid substit...
BACKGROUND: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention ini...
Background People released from correctional settings are at an elevated risk of opioid overdose dea...
BACKGROUND: Opioid use disorder is common in prison populations, and prison release is a high-risk t...
Background Prison inmates face a ten times increased risk of experiencing a fatal dr...
Background and aims. High drug related mortality amongst former prisoners in the 4 weeks following...
Around 65% of people incarcerated in prisons in Australia, America and Europe have a history of drug...
INTRODUCTION AND AIMS: Naloxone is an opioid antagonist used for emergency resuscitation following o...
The naloxone investigation (N-ALIVE) randomized trial commenced in the UK in May 2012, with the prel...
People who inject drugs (PWID) are disproportionately represented among individuals who experience i...
INTRODUCTION: Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate dr...
People who inject drugs (PWID) are disproportionately represented among individuals who experience i...
Aims: Determine the prevalence and frequency at which injecting drug users (IDU) continue to inject ...
Prisoners experience high rates of drug dependence, health problems and premature mortality. Without...
Heroin dependence is a chronic condition associated with significant health and social harms. The mo...
Background: Pre-incarceration HIV transmission behaviors and current attitudes toward opioid substit...
BACKGROUND: Take-home naloxone (THN) programmes are an evidence-based opioid overdose prevention ini...
Background People released from correctional settings are at an elevated risk of opioid overdose dea...
BACKGROUND: Opioid use disorder is common in prison populations, and prison release is a high-risk t...
Background Prison inmates face a ten times increased risk of experiencing a fatal dr...
Background and aims. High drug related mortality amongst former prisoners in the 4 weeks following...
Around 65% of people incarcerated in prisons in Australia, America and Europe have a history of drug...
INTRODUCTION AND AIMS: Naloxone is an opioid antagonist used for emergency resuscitation following o...
The naloxone investigation (N-ALIVE) randomized trial commenced in the UK in May 2012, with the prel...
People who inject drugs (PWID) are disproportionately represented among individuals who experience i...
INTRODUCTION: Ex-prisoners with a history of injecting drug use (IDU) experience disproportionate dr...
People who inject drugs (PWID) are disproportionately represented among individuals who experience i...
Aims: Determine the prevalence and frequency at which injecting drug users (IDU) continue to inject ...
Prisoners experience high rates of drug dependence, health problems and premature mortality. Without...
Heroin dependence is a chronic condition associated with significant health and social harms. The mo...
Background: Pre-incarceration HIV transmission behaviors and current attitudes toward opioid substit...